• Monday, Mar 01, 2021
  • Last Update : 11:56 am

Moderna vaccine effective against UK, SA variants

  • Published at 08:58 pm January 25th, 2021
Moderna
File photo: Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only"and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020 Reuters

But out of caution, the company will test adding a second booster of its vaccine – to make three shots in total – and has begun preclinical studies on a booster specifically for the South African variant

US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa.

But out of caution, the company will test adding a second booster of its vaccine – to make three shots in total – and has begun preclinical studies on a booster specifically for the South African variant.

"We are encouraged by these new data, which reinforce our confidence that the Moderna Covid-19 Vaccine should be protective against these newly detected variants," said Stephane Bancel, Moderna's CEO.

"Out of an abundance of caution and leveraging the flexibility of our mRNA platform, we are advancing an emerging variant booster candidate against the variant first identified in the Republic of South Africa into the clinic."


Also Read - Moderna vaccine receives UK approval


To study the impact of the existing vaccine, called mRNA-1273, Moderna took blood samples from eight people who had received two doses of the vaccine, and two primates that had also been immunized.

For the B.1.1.7 variant, first identified in the UK, there was no impact on the level of neutralizing antibodies -- which bind to the virus and prevent it from invading human cells -- that were produced by the shots.

But for the South African variant, B.1.351, there was a sixfold reduction in the neutralizing antibody level.

Even so, it remained above the quantity that was shown to be protective in earlier tests on primates that were infected on purpose.

The company, which carried out the studies with the National Institutes of Health, has submitted the study to a preprint server so it can be analyzed by the wider scientific community.

57
Facebook 56
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail